Drug companies are still focused on raising prices, but some in the industry realize things need to change

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Italia Notizia Notizia

Italia Ultime Notizie,Italia Notizie

Health care executives gave no indication to bankers and investors at this year's J.P. Morgan Healthcare Conference that their pricing practices would change any time soon.

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

 /  🏆 729. in İT
 

Grazie per il tuo commento. Il tuo commento verrà pubblicato dopo essere stato esaminato.

Liquid or syrup supplements.

Italia Ultime Notizie, Italia Notizie

Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.

House Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices. Why are they being investigated when Trump claimed that drug prices are at an all time low? I just hope the Democrats don't just waste taxpayer dollars with meaningless politically motivated crap like everyone expects them to. This seems a needed topic, but stay away from political theater Democrats. Just watch the SJC in 2018 if you want to see your embarrassment. Nice to see them investigating actual wrong doing and not just investigating HRC again.
Fonte: CNBC - 🏆 12. / 72 Leggi di più »

Analysis | The Health 202: Health-care industry preps offense against Medicare-for-AllThe Health 202: Health-care industry preps offense against Medicare-for-All Can't cure patients, that hurts long term profits! It's Tuesday.
Fonte: washingtonpost - 🏆 95. / 72 Leggi di più »